Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis

An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future

(2010) Jotam Pasipanodya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis

(2010) Zahoor Ahmad et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emerging drugs for the treatment of tuberculosis

(2010) Wing Wai Yew et al.   EXPERT OPINION ON EMERGING DRUGS

Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays

(2010) Natalie Mesens et al.   TOXICOLOGY IN VITRO

Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells

(2010) Jasvir Dhillon et al.   TUBERCULOSIS

R207910 (TMC207) : un nouvel antibiotique pour le traitement de la tuberculose

(2009) N. Lounis et al.   MEDECINE ET MALADIES INFECTIEUSES

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

(2009) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis

(2008) Nicolas Veziris et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs

(2008) G.R. Davies et al.   TUBERCULOSIS